Link Archives

Overall survival data from a 3-arm, randomized, open-label phase 2 study of relacorilant, a selective glucocorticoid receptor modulator, combined with nab-paclitaxel in patients with recurrent platinum-resistant ovarian cancer

February 6, 2023

Colombo et al • 2022 • American Society of Clinical Oncology Annual Meeting

February 5, 2023

Borazanci et al • 2022 • American Society of Clinical Oncology Annual Meeting

February 3, 2023

Mann et al • 2022 • European Network to Cure ALS (ENCALS)

February 2, 2023

Moritis et al • 2022 • European Congress of Endocrinology

February 1, 2023

Brown et al • 2022 • American Association of Clinical Endocrinology (AACE) Annual Meeting

January 30, 2023

Aresta et al • 2021 • Endocr Pract.

January 29, 2023

Giovanelli et al • 2021 • J Endocrinol Invest.

January 28, 2023

Kowdley et al • 2021 • The Liver Meeting 2021 (American Association for the Study of Liver Diseases)

January 27, 2023

Lorusso et al. • 2021 • European Society for Medical Oncology (ESMO) Congress 2021

January 26, 2023

Greenstein et al. • 2021 • Oncotarget . 2021 Jun 22;12(13):1243-1255. doi: 10.18632/oncotarget.27989.